Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

13,500 breast cancer patients join quest for better treatment predictors

NCT ID NCT02338167

Knowledge-focused Sponsor: University Hospital Tuebingen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting blood and tumor samples from 13,500 breast cancer patients, both early-stage and advanced/metastatic. The goal is to discover biomarkers that can predict how well a treatment will work and to improve overall healthcare quality. Researchers will analyze genes, mutations, and other molecular features to better understand the disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better ways to predict which breast cancer treatments work best for each patient, especially in advanced stages.
What could go wrong
This is an observational study, not a treatment trial. It may not directly improve patient outcomes, and biomarker discoveries may take years to validate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 13,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2014

Expected to finish

Jul 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

10,000 patients with breast cancer in the neoadjuvant and adjuvant (early breast cancer) setting independent of treatment regimen. 3500 patients with locally advanced/metastatic breast cancer in any line of treatment (e.g. 1st, 2nd, 3rd, or ≥ 4th line). A patient can only participate after providing informed consent.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for the early breast cancer setting: * Adult breast cancer patients (age ≥18 years) * Patients with breast cancer and no evidence of distant metastases with a diagnosis not longer than 91 days before study entry * Patients, who are able and willing to sign the informed consent form Inclusion Criteria for the advanced/metastatic setting: * Adult women aged ≥18 years * Patients with the diagnosis of invasive breast cancer (in German: Mammakarzinom, as op-posed to "non-invasive"= ductales Carcinoma in situ; irrespective of status of BC, e.g. TNM, re-ceptor status etc.) and * Patients, who are willing and able to sign the informed consent form * Patients with metastatic or locally advanced, inoperable disease proven by clinical measures (i.e. standard imaging) Exclusion Criteria: * Patients who did not sign the informed consent form * Patients, who are not eligible for observation due to non-availability and/or severe comor-bidities as evaluated by the treating physician

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced/metastatic breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced/metastatic breast cancer Breast cancer (early breast cancer)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    52 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Study site

    COMPLETED

    Herne, North Rhine-Westphalia, 44623, Germany

  • Anregiomed gKK Klinikum Ansbach Brustzentrum Westmittelfranken

    RECRUITING

    Ansbach, Bavaria, 91522, Germany

  • Caritas-Krankenhaus St. Josef

    RECRUITING

    Regensburg, Bavaria, 93053, Germany

  • Centrum für Hämatologie und Onkologie Bethanien

    RECRUITING

    Frankfurt am Main, Hesse, 60389, Germany

  • Charité

    COMPLETED

    Berlin, State of Berlin, 10117, Germany

  • DONAUISAR Klinikum

    RECRUITING

    Deggendorf, Bavaria, 94469, Germany

  • Frauenklinik und Poliklinik der Technischen Universität München

    RECRUITING

    München, Bavaria, 81675, Germany

  • Gemeinschaftspraxis für Hämatologie und Onkologie

    RECRUITING

    Langen, Hesse, 63225, Germany

  • Gesellschaft für Medizinische Studien Würselen

    RECRUITING

    Würselen, North Rhine-Westphalia, 52146, Germany

  • Gesundheitszentrum St. Marien GmbH

    RECRUITING

    Amberg, Bavaria, 92224, Germany

  • Gynäkologie und Geburtshilfe im medizinischen Zentrum Bonn

    RECRUITING

    Bonn, North Rhine-Westphalia, 53111, Germany

  • Hämatologische-onkologische Praxis

    COMPLETED

    Augsburg, Bavaria, 86150, Germany

  • Immanuel Klinik und Poliklinik Rüdersdorf GmbH

    RECRUITING

    Rüdersdorf, Brandenburg, 15562, Germany

  • Institut für Versorgungsforschung

    RECRUITING

    Mayen, Rhineland-Palatinate, 56727, Germany

  • Institut für Versorgungsforschung in der Onkologie GbR

    RECRUITING

    Koblenz, North Rhine-Westphalia, 56068, Germany

  • Klinik für Frauenheilkunde, Universitätsklinikum Freiburg

    RECRUITING

    Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany

  • Klinik für Gynäkologie und Geburtshilfe

    COMPLETED

    Kiel, Schleswig-Holstein, 24105, Germany

  • Klinik für Gynäkologie und Geburtshilfe, Helios Kliniken

    RECRUITING

    Berlin, State of Berlin, 13125, Germany

  • Kliniken Essen-Mitte

    COMPLETED

    Essen, North Rhine-Westphalia, 45136, Germany

  • Klinikum Augsburg

    RECRUITING

    Augsburg, Bavaria, 86156, Germany

  • Klinikum Bayreuth

    RECRUITING

    Bayreuth, Bavaria, 95445, Germany

  • Klinikum Chemnitz gGmbH

    RECRUITING

    Chemnitz, Saxony, 09116, Germany

  • Klinikum Darmstadt Frauenklinik

    RECRUITING

    Darmstadt, Hesse, 64283, Germany

  • Klinikum Fürth

    RECRUITING

    Fürth, Bavaria, 90766, Germany

  • Klinikum Kassel GmbH

    RECRUITING

    Kassel, Hesse, 34125, Germany

  • Klinikum Sindelfingen-Böblingen gGmbH

    RECRUITING

    Böblingen, Baden-Wurttemberg, 71032, Germany

  • Klinikum der Universität München Frauenklinik

    RECRUITING

    München, Bavaria, 81337, Germany

  • Kreiskrankenhaus Torgau

    RECRUITING

    Torgau, Saxony, 04860, Germany

  • Lahn-Dill-Kliniken GmbH Klinikum Wetzlar

    COMPLETED

    Wetzlar, Hesse, 35578, Germany

  • MVZ am Klinikum Aschaffenburg - Zweigpraxis für Hämatologie und Onkologie

    RECRUITING

    Hösbach, Bavaria, 63768, Germany

  • Marienhospital

    RECRUITING

    Bottrop, North Rhine-Westphalia, 46236, Germany

  • MediOnko-Institut GbR

    RECRUITING

    Berlin, State of Berlin, 10367, Germany

  • NCT Heidelberg

    RECRUITING

    Heidelberg, Baden-Wurttemberg, 69120, Germany

  • Niels-Stensen-Kliniken

    RECRUITING

    Georgsmarienhütte, Lower Saxony, 49124, Germany

  • Onkologie Elisenhof, München

    COMPLETED

    München, Bavaria, 80335, Germany

  • Onkologie Lerchenfeld

    COMPLETED

    Hamburg, Free and Hanseatic City of Hamburg, 22081, Germany

  • Onkologische Schwerpunktpraxis Leer-Emden

    RECRUITING

    Leer, Lower Saxony, 26789, Germany

  • Onkologisches Zentrum Donauwörth

    RECRUITING

    Donauwörth, Bavaria, 86609, Germany

  • Praxis Onkologie und Hämatologie

    COMPLETED

    Recklinghausen, North Rhine-Westphalia, 45657, Germany

  • Praxis für Frauenheilkunde und Geburtshilfe

    RECRUITING

    Fürstenwalde, Brandenburg, 015517, Germany

  • Praxisklinik am Rosengarten

    RECRUITING

    Mannheim, Baden-Wurttemberg, 68165, Germany

  • Rottal-Inn-Kliniken GmbH

    RECRUITING

    Eggenfelden, Bavaria, 84307, Germany

  • Ruppiner Kliniken GmbH, Hochschulklinikum der Med. Hochschule Brandenburg

    RECRUITING

    Neuruppin, Brandenburg, 16816, Germany

  • Schwerpunktpraxis für Hämatologie und Onkologie

    RECRUITING

    Kaiserslautern, Rhineland-Palatinate, 67655, Germany

  • Sozialstiftung Bamberg Klinikum am Bruderwald

    RECRUITING

    Bamberg, Bavaria, 96049, Germany

  • St. Vincenz-Krankenhaus GmbH

    RECRUITING

    Paderborn, North Rhine-Westphalia, 33098, Germany

  • Uniklinik RWTH Aachen

    RECRUITING

    Aachen, North Rhine-Westphalia, 52074, Germany

  • Universitäres Krebszentrum Leipzig

    RECRUITING

    Leipzig, Saxony, 04103, Germany

  • Universitätsfrauenklinik Düsseldorf

    RECRUITING

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

  • Universitätsfrauenklinik Erlangen

    RECRUITING

    Erlangen, Bavaria, 91012, Germany

  • Universitätsfrauenklinik Tübingen

    RECRUITING

    Tübingen, Baden-Wurttemberg, Germany

  • Universitätsfrauenklinik Ulm

    RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

  • Universitätsklinik Dresden

    RECRUITING

    Dresden, Saxony, 01307, Germany

  • Universitätsklinikum Halle (Saale)

    RECRUITING

    Halle, Saxony-Anhalt, 06120, Germany

  • Universitätsklinikum Hamburg-Eppendorf

    RECRUITING

    Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany

  • Universitätsklinikum Schleswig-Holstein

    RECRUITING

    Lübeck, Schleswig-Holstein, 23538, Germany

  • Universitätsklinikum Würzburg

    RECRUITING

    Würzburg, Bavaria, 97080, Germany

  • ViDia Christliche Kliniken Karlsruhe

    RECRUITING

    Karlsruhe, Baden-Wurttemberg, 76135, Germany

  • g.SUND Gynäkologie Kompetenzzentrum Stralsund

    RECRUITING

    Stralsund, Mecklenburg-Vorpommern, 18435, Germany

  • medius KLINIKEN gGmbH, medius KLINIK Ostfildern-Ruit

    RECRUITING

    Ostfildern, 73760, Germany

  • medius Klinik Nürtingen

    RECRUITING

    Nürtingen, Baden-Wurttemberg, 72622, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.